WDR81

WD repeat domain 81, the group of WD repeat domain containing|BEACH domain containing |Protein phosphatase 1 regulatory subunits|Armadillo like helical domain containing

Basic information

Region (hg38): 17:1716523-1738599

Links

ENSG00000167716NCBI:124997OMIM:614218HGNC:26600Uniprot:Q562E7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (Limited), mode of inheritance: AR
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (Strong), mode of inheritance: AR
  • cerebellar ataxia, intellectual disability, and dysequilibrium (Supportive), mode of inheritance: AR
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2; Hydrocephalus, nonsyndromic, autosomal recessive 3ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic16371500; 21885617; 25558065; 26437881; 28556411

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the WDR81 gene.

  • not provided (6 variants)
  • Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (3 variants)
  • Inborn genetic diseases (2 variants)
  • Microlissencephaly (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDR81 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
90
clinvar
20
clinvar
113
missense
3
clinvar
209
clinvar
15
clinvar
1
clinvar
228
nonsense
4
clinvar
7
clinvar
1
clinvar
12
start loss
0
frameshift
4
clinvar
3
clinvar
1
clinvar
8
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
2
7
1
11
non coding
1
clinvar
2
clinvar
3
clinvar
3
clinvar
9
Total 9 14 217 108 24

Highest pathogenic variant AF is 0.0000328

Variants in WDR81

This is a list of pathogenic ClinVar variants found in the WDR81 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-1716626-C-T Likely benign (Aug 01, 2024)2578776
17-1724976-G-C Inborn genetic diseases Uncertain significance (May 20, 2024)2345695
17-1724990-G-A Inborn genetic diseases Uncertain significance (Jul 19, 2023)2602557
17-1725010-G-A Likely benign (Jun 01, 2023)2570964
17-1725027-C-A Inborn genetic diseases Uncertain significance (Oct 10, 2023)3190292
17-1725037-C-G Inborn genetic diseases Uncertain significance (Mar 27, 2023)2529992
17-1725080-G-C Inborn genetic diseases Uncertain significance (Mar 30, 2024)3332962
17-1725084-C-T Inborn genetic diseases Uncertain significance (Dec 01, 2022)2330994
17-1725100-G-C Likely benign (May 20, 2018)745903
17-1725110-G-A Inborn genetic diseases Uncertain significance (Apr 18, 2023)2525546
17-1725165-G-T Inborn genetic diseases Uncertain significance (Jul 09, 2021)2216734
17-1725168-G-A Inborn genetic diseases Uncertain significance (Nov 09, 2023)3190262
17-1725176-CT-C Pathogenic (Feb 09, 2022)1687637
17-1725204-T-C Inborn genetic diseases Uncertain significance (Jun 06, 2023)2560831
17-1725229-C-T Benign (Dec 31, 2019)783746
17-1725254-C-T Inborn genetic diseases Uncertain significance (Jul 30, 2023)2614654
17-1725287-C-T Likely benign (Aug 28, 2017)718887
17-1725291-G-C Inborn genetic diseases Uncertain significance (Nov 15, 2023)3190273
17-1725296-C-T Inborn genetic diseases Uncertain significance (Sep 23, 2023)3190274
17-1725300-G-C Inborn genetic diseases Uncertain significance (Nov 17, 2022)2326671
17-1725340-C-A Inborn genetic diseases Likely benign (May 01, 2024)3332963
17-1725341-G-C Inborn genetic diseases Uncertain significance (Feb 27, 2024)3190280
17-1725418-T-A Inborn genetic diseases Uncertain significance (Mar 02, 2023)2493522
17-1725435-G-A Inborn genetic diseases Uncertain significance (Jun 06, 2023)2525898
17-1725441-C-T Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 Uncertain significance (Jan 01, 2019)982855

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
WDR81protein_codingprotein_codingENST00000409644 1022077
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.75e-81.001255570471256040.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.1110001.21e+30.8290.000079912394
Missense in Polyphen391528.730.73955658
Synonymous1.605025500.9130.00003894227
Loss of Function4.572463.20.3800.00000336664

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007230.000709
Ashkenazi Jewish0.0001020.0000993
East Asian0.0001640.000163
Finnish0.0005040.000462
European (Non-Finnish)0.0001620.000159
Middle Eastern0.0001640.000163
South Asian0.00006570.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome (PubMed:27126989). May also play a role in aggrephagy, the macroautophagic degradation of ubiquitinated protein aggregates. In this process, may regulate the interaction of SQSTM1 with ubiquitinated proteins and also recruit MAP1LC3C (PubMed:28404643). May also be involved in maintenance of normal mitochondrial structure and organization (By similarity). {ECO:0000250|UniProtKB:Q5ND34, ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27126989, ECO:0000269|PubMed:28404643}.;

Intolerance Scores

loftool
0.504
rvis_EVS
-1.76
rvis_percentile_EVS
2.34

Haploinsufficiency Scores

pHI
0.266
hipred
Y
hipred_score
0.563
ghis
0.523

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.985

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerHighMediumHigh

Mouse Genome Informatics

Gene name
Wdr81
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
ubiquitin-dependent protein catabolic process;mitochondrion organization;negative regulation of phosphatase activity;aggrephagy;regulation of phosphatidylinositol 3-kinase activity;early endosome to late endosome transport;protein stabilization
Cellular component
autophagosome membrane;mitochondrion;lysosomal membrane;endoplasmic reticulum membrane;Golgi apparatus;cytosol;extrinsic component of endosome membrane;early endosome membrane;late endosome membrane
Molecular function
protein binding;phosphatidylinositol 3-kinase regulator activity;K63-linked polyubiquitin modification-dependent protein binding